Citation Impact
Citing Papers
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Gastric cancer
2016 Standout
The Surgical Management of Oral Cancer
2006
The biologic basis for neuroblastoma heterogeneity and risk stratification
2005
Acromegaly
2006 Standout
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer
2003
Efficacy and safety of cefepime: a systematic review and meta-analysis
2007
Testicular Germ-Cell Cancer
1997 Standout
Genetic Staging of Unresectable or Metastatic Neuroblastomain Infants: a Pediatric Oncology Group Study
1997
MONOTHERAPY WITH PIPERACILLIN/TAZOBACTAM VERSUS CEFEPIME AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC CANCER PATIENTS: A Randomized Comparison
2006
β1 integrin antagonism on adherent, differentiated human neuroblastoma cells triggers an apoptotic signaling pathway
2000
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Hedgehog-Regulated Processing of Gli3 Produces an Anterior/Posterior Repressor Gradient in the Developing Vertebrate Limb
2000 Standout
Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation
1989
Hedgehog and Patched in Neural Development and Disease
1998
Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas
1997
Primary central nervous system lymphoma
1999
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
Primary CNS Lymphoma: Treatment with Combined Chemotherapy and Radiotherapy
1999
The Hedgehog and Wnt signalling pathways in cancer
2001 StandoutNature
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
2003 Standout
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome.
1998
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas
2004
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Epigenetics in Cancer
2008 Standout
Diagnostic and therapeutic management of cancer of an unknown primary
2003
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d’Etude des Lymphomes de l’Adulte (GELA)
2009
The continuing increase in the incidence of primary central nervous system non‐Hodgkin lymphoma
2002
The microenvironment of the tumour–host interface
2001 StandoutNature
Circadian rhythms and cancer chemotherapy
1995
Ultrasonographic Differentiation of Benign From Malignant Neck Lymphadenopathy in Thyroid Cancer
2006
Oncogene amplification in solid tumors
1999
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine
2000 StandoutNature
Malignant Gliomas in Adults
2008 Standout
Capecitabine: A review
2005
Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.
1993
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
2006
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
2002 Standout
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
2003 Standout
Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
1998
Head and Neck Cancer
1993 Standout
Primary brain tumours in adults
2003
Neuroblastoma
2007 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
A Randomized, Open-Label, Multicenter Comparative Study of the Efficacy and Safety of Piperacillin-Tazobactam and Cefepime for the Empirical Treatment of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies
2006
Primary brain tumours in adults
2012 Standout
Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases.
1991
Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in Neuroblastoma
1991
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin’s lymphoma
2001
Testicular germ cell tumors and human immunodeficiency virus infection: a report of 26 cases. Italian Cooperative Group on AIDS and Tumors.
1995
MYC oncogenes and human neoplastic disease
1999
Natural History and Biology of Stage A Neuroblastoma: A Pediatric Oncology Group Study
2000
Treatment of febrile neutropenic patients with cancer who require hospitalization
2003
Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia
2001
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?
2002
Delayed Neurotoxicity in Primary Central Nervous System Lymphoma
2005
Prediction of Gram-Negative Bacteremia in Patients with Cancer and Febrile Neutropenia by Means of Interleukin-8 Levels in Serum: Targeting Empirical Monotherapy versus Combination Therapy
2001
Brain Tumors
2001 Standout
Randomized, Double-Blind, Multicenter Trial Comparing Clinafloxacin with Imipenem as Empirical Monotherapy for Febrile Granulocytopenic Patients
2001
Guidelines for Acromegaly Management
2002
Head and Neck Cancer
2001 Standout
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Gender differences in drug responses
2006
Myocarditis
2009 Standout
Trends in Reported Incidence of Primary Malignant Brain Tumors in Children in the United States
1998
Phase I and Pharmacokinetic Study of the Oral Fluoropyrimidine S-1 on a Once-Daily-for-28-Day Schedule in Patients with Advanced Malignancies
2004
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Myocarditis
2006 Standout
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
High-dose rapid schedule chemotherapy for disseminated neuroblastoma
1992
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Importance of Radiotherapy in the Outcome of Patients With Primary CNS Lymphoma: An Analysis of the CHOD/BVAM Regimen Followed by Two Different Radiotherapy Treatments
2002
Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma
2001
High-Dose Chemotherapy With Autologous Stem-Cell Transplantation and Hyperfractionated Radiotherapy As First-Line Treatment of Primary CNS Lymphoma
2006
Small molecule modulation of Smoothened activity
2002 Standout
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma
1995
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Reply to Paul et al
2009
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience
2009
Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre: Rational approach towards the patient with cancer, fever and neutropenia
2005
Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group
2005
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
1998
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
2008
Molecular Biology of Neuroblastoma
1999
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Impact of Primary Prophylaxis With Granulocyte Colony-Stimulating Factor on Febrile Neutropenia and Mortality in Adult Cancer Patients Receiving Chemotherapy: A Systematic Review
2007
p53 Alterations Predict Tumor Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Series
2000
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
2001 StandoutNobel
Biologic Variables in the Outcome of Stages I and II Neuroblastoma Treated With Surgery as Primary Therapy: A Children’s Cancer Group Study
2000
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer
1991 Standout
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
1991
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
2008
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Works of Antoine Thyss being referenced
Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
1995
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
1997
Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.
1993
Expression of integrin receptors on 45 clinical neuroblastoma specimens
1991
Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
1995
Combination of Cisplatin-Doxorubicin-Cyclophosphamide in Adenocarcinoma of Unknown Primary Site
2001
Expression of P-glycoprotein restricted to normal cells in neuroblastoma biopsies
1991
Phase II Trial of a Paclitaxel-Carboplatin Combination in Recurrent Squamous Cell Carcinoma of the Head and Neck
2000
Relationship between fluorouracil systemic exposure and tumor response and patient survival.
1994
Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?
1998
Influence of sex and age on fluorouracil clearance.
1992
Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.
1995
Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy
1993
Extracerebral toxoplasmosis in the acquired immunodeficiency syndrome (AIDS)
1993
Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?
2004
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.
1996
Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal
1992
Preirradiation chemotherapy including “eight drugs in 1 day” regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study
1995
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.
1998
Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck
1986
High-dose therapy in multiple myeloma: A prospective randomized study of the “intergroupe français du myelome”
1996
Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome.
1993
[Combination transurethral resection and systematic chemotherapy as primary treatment of infiltrating bladder tumors (pT2-pT4 NxM0)].
1988
Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
1987
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer)
1998
Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients.
1988
Lymphomatous superficial lymph nodes: US detection.
1987